RECRUITINGOBSERVATIONAL
Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)
Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME) Study
About This Trial
Almost 90% of systemic sclerosis (SSc) patients experience hand function limitation, which leads to impaired daily functioning and work participation. An important cause of impaired hand function are contractures of the hand, which are reported in up to a half of patients. With this longitudinal cohort study in patients with SSc and VEDOSS (very early diagnosis of systemic sclerosis) the investigators aim to gain more insight into processes involved in hand function impairment.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age \> 18 years
Who Should NOT Join This Trial:
- Patients with diabetic cheiroarthropathy and Dupuytren's disease, based on expert opinion
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age \> 18 years
Exclusion Criteria:
* Patients with diabetic cheiroarthropathy and Dupuytren's disease, based on expert opinion
Treatments Being Tested
DIAGNOSTIC_TEST
Imaging, blood samples, fuctional tests and physical examination
Imaging, blood samples, fuctional tests and physical examination
Locations (1)
UMC Utrecht
Utrecht, Netherlands